← Leaderboards
Chun R. Chao
Kaiser Foundation Research Institute
$8,592,282
Attributed
$11,006,821
Total exposure
6
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.4M · FY2008–25$2M$1.5M$1M$500K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$11,656,813 · 7
By mechanism
R01$10,612,087 · 5
U54$649,992 · 1
R21$394,734 · 1
Top collaborators
- Erin Elizabeth Hahn5 shared
- Michael J Silverberg3 shared
- Douglas Allen Corley1 shared
Most similar at Kaiser Foundation Research Institute
Same institution · by research overlap
- Michael J Silverberg$13,556,779
- Amanda F. Petrik$2,043,704
- Erin Elizabeth Hahn$7,456,765
Others in their field
Top investigators on “California”
- Gary D Acton · University Of California-Davis$320,373,312
- Mitchell J Malone · Texas A&M Research Foundation$320,373,312
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$298,740,071
- Judith S. Currier · University Of California Los Angeles$152,313,768
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$137,892,773
- Sharon A Nachman · Johns Hopkins University$135,132,510
Research focus
CaliforniaMalignant NeoplasmsInsightRecommendationUnited StatesEnvironmentDiagnosisCohortVariantCharacteristicsCaringResourcesMolecularSubgroupCancer DiagnosisAffectElectronic Health RecordBiometryArchivesResponseSpecimenClinicDesignBase
Grant awards (22)
Effectiveness of the HPV Vaccine in Immunocompromised Populations$827,605
R01 · FY2025 · AI
Effectiveness and Mechanisms of Multilevel Implementation Strategies to Improve Cancer Prevention Behaviors: A Cluster Randomized Trial$612,449
R01 · FY2025 · CA · contact PI
Effectiveness of the HPV Vaccine in Immunocompromised Populations$826,914
R01 · FY2024 · AI
Effectiveness and Mechanisms of Multilevel Implementation Strategies to Improve Provider Recommendation and Advance HPV Vaccination: a Cluster Randomized Trial$593,242
R01 · FY2024 · CA · contact PI
Effectiveness and Mechanisms of Multilevel Implementation Strategies to Improve Provider Recommendation and Advance HPV Vaccination: a Cluster Randomized Trial$627,341
R01 · FY2023 · CA · contact PI
A Case-Control Study to Evaluate Broad-Spectrum Antibiotic use and High Birth Weight as Potential Risk Factors for Early-Onset Colorectal Cancer$360,475
R01 · FY2023 · CA · contact PI
Effectiveness and Mechanisms of Multilevel Implementation Strategies to Improve Provider Recommendation and Advance HPV Vaccination: a Cluster Randomized Trial$649,552
R01 · FY2022 · CA · contact PI
A Case-Control Study to Evaluate Broad-Spectrum Antibiotic use and High Birth Weight as Potential Risk Factors for Early-Onset Colorectal Cancer$362,122
R01 · FY2022 · CA · contact PI
Effectiveness and Mechanisms of Multilevel Implementation Strategies to Improve Provider Recommendation and Advance HPV Vaccination: a Cluster Randomized Trial$691,976
R01 · FY2021 · CA · contact PI
A Case-Control Study to Evaluate Broad-Spectrum Antibiotic use and High Birth Weight as Potential Risk Factors for Early-Onset Colorectal Cancer$379,857
R01 · FY2021 · CA · contact PI
Identification of DNA methylation markers for risk of metastasis in localized pro$646,064
R01 · FY2019 · CA · contact PI
Identification of DNA methylation markers for risk of metastasis in localized pro$594,195
R01 · FY2018 · CA · contact PI
Identification of DNA methylation markers for risk of metastasis in localized pro$566,816
R01 · FY2017 · CA · contact PI
Follow-up care and preventive service use among survivors of adolescent and young adult cancer.$177,068
R21 · FY2017 · CA · contact PI
Identification of DNA methylation markers for risk of metastasis in localized pro$571,325
R01 · FY2016 · CA · contact PI
Follow-up care and preventive service use among survivors of adolescent and young adult cancer.$217,666
R21 · FY2016 · CA · contact PI
Identification of DNA methylation markers for risk of metastasis in localized pro$639,726
R01 · FY2015 · CA · contact PI
Optimizing Colonscopy & Fecal Immunochemical Tests for Community-Based Screening$649,992
U54 · FY2014 · CA
Prognostic Markers for HIV-Postive Diffuse Large B-Cell Lymphoma$301,385
R01 · FY2011 · CA · contact PI
Prognostic Markers for HIV-Postive Diffuse Large B-Cell Lymphoma$357,589
R01 · FY2010 · CA · contact PI
Prognostic Markers for HIV-Postive Diffuse Large B-Cell Lymphoma$503,454
R01 · FY2009 · CA · contact PI
Prognostic Markers for HIV-Postive Diffuse Large B-Cell Lymphoma$500,000
R01 · FY2008 · CA · contact PI